Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
מצבים רפואיים
IgA Nephropathy
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Univ of Alabama/Birmingham, Birmingham, Alabama, United States
Contact: Study coordinator (Principal Investigator)Arizona Kidney Disease & Hypertension Centers (AKDHC), Glendale, Arizona, United States
Contact: Study coordinator (Principal Investigator)The Medical Research Group, Inc., Fresno, California, United States
Contact: Principal Investigator (Harpreet Dhindsa)UCI Health-UCI Medical Center, Orange, California, United States
Contact: Study coordinator (Principal Investigator)Loma Linda University, San Bernardino, California, United States
Contact: Principal Investigator (Sayna Norouzi)UCSF Health-UCSF Medical Center-Parnassus - Nephrology and Hypertension Faculty Practice, San Francisco, California, United States
PIStanford University, Stanford, California, United States
Contact: Study coordinator (Principal Investigator)University of Colorado Hospital (UCH) - Kidney Disease and Hypertension Clinic - Anschutz Medical Campus Location, Aurora, Colorado, United States
Contact: Study coordinator (Principal Investigator)Yale University Nephrology Clinical Trials Program, New Haven, Connecticut, United States
Contact: Study coordinator (Principal Investigator)Florida Kidney Physicians, Boca Raton, Florida, United States
Contact: Study coordinator (Principal Investigator)Central Florida Kidney Specialists, Orlando, Florida, United States
Contact: Study coordinator (Principal Investigator)Southeastern Clinical Research Institute, LLC, Augusta, Georgia, United States
Contact: Study coordinator (Principal Investigator)Cobb Nephrology Hypertension Associates, PC, Austell, Georgia, United States
Contact: Study coordinator (Principal Investigator)Georgia Nephrology, Lawrenceville, Georgia, United States
Contact: Principal Investigator (James Tumlin)University of Louisville, Louisville, Kentucky, United States
Contact: Principal Investigator (Gunjan Garg)Ochsner Health, New Orleans, New Orleans, Louisiana, United States
Contact: Study coordinator (Principal Investigator)University of Maryland Division of Nephrology, Baltimore, Maryland, United States
Contact: Principal Investigator (Preeti Chandra)Boston Medical Center; Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, United States
Contact: Principal Investigator (Ashish Upadhyay)University of Minnesota Health Fairview, Minneapolis, Minnesota, United States
Contact: Principal Investigator (Nattawat Klomjit)Washington University in St. Louis, St Louis, Missouri, United States
Contact: Study coordinator (Principal Investigator)University of New Mexico, Albuquerque, New Mexico, United States
Contact: Study coordinator (Principal Investigator)Renal Medical Associates, Albuquerque, New Mexico, United States
Contact: Study coordinator (Principal Investigator)New York Nephrology Vasculitis and Glomerular Center, Clifton Park, New York, United States
Contact: Principal Investigator (Frank Cortazar)Chinatown Kidney Care, PLLC, New York, New York, United States
Contact: Study coordinator (Principal Investigator)Icahn School of Medicine at Mount Sinai, New York, New York, United States
Contact: Study coordinator (Principal Investigator)North Carolina Nephrology, P.A, Raleigh, North Carolina, United States
Contact: Principal Investigator (Michael Casey)Ohio State University, Columbus, Ohio, United States
Contact: Study coordinator (Principal Investigator)Oregon Health & Science University (OHSU) - Nephrology and Hypertension Clinic, Portland, Oregon, United States
Contact: Study coordinator (Principal Investigator)University of Pennsylvania Philadelphia, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Principal Investigator)Dallas Renal Group, Dallas, Texas, United States
Contact: Study coordinator (Principal Investigator)MedResearch Inc, El Paso, Texas, United States
Contact: Study coordinator (Principal Investigator)The University of Texas Medical Branch UTMB, Galveston, Texas, United States
Contact: Study coordinator (Principal Investigator)Memorial Hermann Houston, Houston, Texas, United States
Contact: Study coordinator (Principal Investigator)Prolato Clinical Research Center, Houston, Texas, United States
Contact: Study coordinator (Principal Investigator)The Kidney Institute/Houston, Houston, Texas, United States
Contact: Study coordinator (Principal Investigator)Dallas Nephrology Associates McKinney, McKinney, Texas, United States
Contact: Study coordinator (Principal Investigator)Permian Basin Kidney Center, Odessa, Texas, United States
Contact: Study coordinator (Principal Investigator)Advanced Renal Care Institute, Mayagüez, Puerto Rico
Contact: Study coordinator (Principal Investigator)
מובילי המחקר
Krassimir Mitchev
Study Director
Calliditas Therapeutics